Positives

• A patient-reported outcomes survey of more than 150 treatments in ME/CFS and Long COVID found acetyl-L-carnitine at ≥500 mg/day produced a significant positive effect on patient-reported well-being, with 41.7% of users reporting benefit PNAS.
  
  

Negatives

• In one ME/CFS L-carnitine trial, eight patients dropped out because they could not tolerate the resulting overstimulation and insomnia, and forum users have reported disturbed sleep from even small ALCAR doses Phoenix Rising.
• Patients have shared that L-carnitine had no effect at all for them, with one noting LCF can crash some people with massive fatigue while ALCAR helps others, so individual response varies widely Phoenix Rising.

Hurdles & Side Effects

• Long-term L-carnitine use raises trimethylamine N-oxide (TMAO), which has been associated with cardiovascular risk in some observational data — a tradeoff worth discussing with cardiology if a patient already has elevated TMAO or vascular risk factors European Archives of Psychiatry and Clinical Neuroscience.